Olesen Margrethe A, Pradenas Eugenia, Villavicencio-Tejo Francisca, Porter George A, Johnson Gail V W, Quintanilla Rodrigo A
Laboratory of Neurodegenerative Diseases, Instituto de Ciencias Biomédicas, Facultad de Ciencias de La Salud, Universidad Autónoma de Chile, Santiago, Chile.
Department of Pediatrics, University of Rochester Medical Center, New York, USA.
Free Radic Biol Med. 2024 May 1;217:141-156. doi: 10.1016/j.freeradbiomed.2024.03.017. Epub 2024 Mar 27.
Current studies indicate that pathological modifications of tau are associated with mitochondrial dysfunction, synaptic failure, and cognitive decline in neurological disorders and aging. We previously showed that caspase-3 cleaved tau, a relevant tau form in Alzheimer's disease (AD), affects mitochondrial bioenergetics, dynamics and synaptic plasticity by the opening of mitochondrial permeability transition pore (mPTP). Also, genetic ablation of tau promotes mitochondrial function boost and increased cognitive capacities in aging mice. However, the mechanisms and relevance of these alterations for the cognitive and mitochondrial abnormalities during aging, which is the primary risk factor for AD, has not been explored. Therefore, in this study we used aging C57BL/6 mice (2-15 and 28-month-old) to evaluate hippocampus-dependent cognitive performance and mitochondrial function. Behavioral tests revealed that aged mice (15 and 28-month-old) showed a reduced cognitive performance compared to young mice (2 month). Concomitantly, isolated hippocampal mitochondria of aged mice showed a significant decrease in bioenergetic-related functions including increases in reactive oxygen species (ROS), mitochondrial depolarization, ATP decreases, and calcium handling defects. Importantly, full-length and caspase-3 cleaved tau were preferentially present in mitochondrial fractions of 15 and 28-month-old mice. Also, aged mice (15 and 28-month-old) showed an increase in cyclophilin D (CypD), the principal regulator of mPTP opening, and a decrease in Opa-1 mitochondrial localization, indicating a possible defect in mitochondrial dynamics. Importantly, we corroborated these findings in immortalized cortical neurons expressing mitochondrial targeted full-length (GFP-T4-OMP25) and caspase-3 cleaved tau (GFP-T4C3-OMP25) which resulted in increased ROS levels and mitochondrial fragmentation, along with a decrease in Opa-1 protein expression. These results suggest that tau associates with mitochondria and this binding increases during aging. This connection may contribute to defects in mitochondrial bioenergetics and dynamics which later may conduce to cognitive decline present during aging.
目前的研究表明,tau蛋白的病理修饰与神经疾病和衰老过程中的线粒体功能障碍、突触功能障碍及认知能力下降有关。我们之前发现,半胱天冬酶-3切割的tau蛋白(阿尔茨海默病(AD)中的一种相关tau蛋白形式)通过线粒体通透性转换孔(mPTP)的开放影响线粒体生物能量学、动力学和突触可塑性。此外,tau基因敲除可促进衰老小鼠的线粒体功能增强并提高认知能力。然而,在衰老过程中(AD的主要危险因素),这些改变对认知和线粒体异常的机制及相关性尚未得到探讨。因此,在本研究中,我们使用衰老的C57BL/6小鼠(2至15个月龄和28个月龄)来评估海马体依赖的认知表现和线粒体功能。行为测试显示,与年轻小鼠(2个月龄)相比,老年小鼠(15个月龄和28个月龄)的认知表现下降。与此同时,老年小鼠分离的海马体线粒体在生物能量相关功能方面显著降低,包括活性氧(ROS)增加、线粒体去极化、ATP减少以及钙处理缺陷。重要的是,全长和半胱天冬酶-3切割的tau蛋白优先存在于15个月龄和28个月龄小鼠的线粒体组分中。此外,老年小鼠(15个月龄和28个月龄)的亲环蛋白D(CypD)增加,CypD是mPTP开放的主要调节因子,而线粒体外膜转位酶1(Opa-1)在线粒体中的定位减少,表明线粒体动力学可能存在缺陷。重要的是,我们在表达线粒体靶向全长tau蛋白(绿色荧光蛋白-T4-OMP25)和半胱天冬酶-3切割tau蛋白(绿色荧光蛋白-T4C3-OMP25)的永生化皮质神经元中证实了这些发现,这导致ROS水平升高和线粒体碎片化,同时Opa-1蛋白表达减少。这些结果表明,tau蛋白与线粒体相关,且这种结合在衰老过程中增加。这种联系可能导致线粒体生物能量学和动力学缺陷,随后可能导致衰老过程中出现的认知能力下降。